Get 40% Off
🚀 Our AI Picked 6 Stocks that Jumped +25% in Q1. Which Picks Will Soar in Q2?Unlock full list

5 Best and Worst Performing Small-Cap Stocks in October 2022

Published 11/08/2022, 01:45 AM
Updated 05/14/2017, 06:45 AM

Small-cap stocks can offer big returns quickly, especially when the economy is rebounding from a slowdown. This is because businesses witness robust earnings growth when the economy is recovering.

On the other hand, small-cap stocks can also offer significant losses because of their volatile nature. To give an idea of the gains you can make and losses you can incur, discussed below are the five best and worst-performing small-cap stocks in October 2022.

Five Best-Performing Small-Cap Stocks In October 2022

We have used the October return data from finviz.com to develop the five best and worst-performing small-cap stocks in October 2022. Here are the five best-performing small-cap stocks in October 2022:

  1. Akouos (95%)

Founded in 2016 and headquartered in Boston, Mass., this company develops precision genetic medicines to restore and preserve hearing in genetically-defined patients. Akouos (NASDAQ:AKUS) shares are up by almost 52% year to date and up over 312% in the last three months.

As of this writing, Akouos shares are trading above $13 with a 52-week range of $2.32 to $13.35, giving the company a market capitalization of more than $485 million.

  1. Immunovant (101%)

Founded in 2018 and headquartered in New York City, it is a clinical-stage biopharmaceutical company focusing on providing normal lives to patients with autoimmune diseases. Immunovant (NASDAQ:IMVT) shares are up by almost 40% year to date and up almost 151% in the last three months.

As of this writing, Immunovant shares are trading above $11 with a 52-week range of $3.15 to $12.42, giving the company a market cap of more than $1.40 billion.

  1. FingerMotion (118%)

Founded in 2014 and headquartered in New York City, this company offers mobile payment and recharge services in China. FingerMotion Inc (NASDAQ:FNGR) shares are down by almost 4% year to date but are up by almost 512% in the last three months.

FingerMotion shares are trading above $6.80 with a 52-week range of $0.62 to $9.80, giving the company a market capitalization of more than $320 million.

  1. Tango Therapeutics (122%)

Founded in 2017 and headquartered in Boston, Mass., this company discovers novel drugs to deliver targeted therapies to cancer patients. Tango Therapeutics (NASDAQ:TNGX) shares are down by almost 32% year to date but are up by almost 75% in the last three months.

As of this writing, Tango Therapeutics shares are trading at above $7.40, with a 52-week range of $3.18 to $14.31, giving the company a market capitalization of more than $650 million.

  1. Biohaven (163%)

Founded in 2013 and headquartered in New Haven, Conn., Biohaven Pharmaceutical Holding (NYSE:BHVN) is a modern pharmaceutical company aiming to change people's lives with unmet medical needs.

Biohaven shares are trading above $14 with a 52-week range of $5.54 to $17.39, giving the company a market capitalization of more than $940 million.

Five Worst Performing Small-Cap Stocks in October 2022

These were the five worst-performing small-cap stocks in October 2022:

  1. Nutex Health (-46%)

It is a technology-enabled healthcare services company founded in 2011 and headquartered in Houston, Texas. Nutex Health (NASDAQ:NUTX) shares are down by almost 83% year to date and down over 79% in the last three months.

As of this writing, Nutex Health shares are trading above $0.72 with a 52-week range of $0.50 to $52.80, giving the company a market capitalization of more than $480 million.

  1. ACM Research (-49%)

Founded in 1998 and headquartered in Fremont, Calif., this company develops, makes, and sells single-wafer wet cleaning equipment. Acm Research (NASDAQ:ACMR) shares are down by almost 77% year to date and down almost 66% in the last three months.

As of this writing, ACM Research shares are trading above $6.50 with a 52-week range of $5.46 to $37.12, giving the company a market capitalization of more than $360 million.

  1. TuSimple Holdings (-55%)

Founded in 2015 and headquartered in San Diego, Calif., this company operates and develops autonomous trucks. Tusimple Holdings (NASDAQ:TSP) shares are down by over 90% year to date and down over 71% in the last three months.

As of this writing, TuSimple Holdings shares are trading above $2.70 with a 52-week range of $2.83 to $43.79, giving the company a market cap of more than $760 million.

  1. Cano Health (-59%)

Founded in 2009 and headquartered in Miami, Fla., this company operates primary care centers and supports related medical practices in primary care for seniors. Cano Health (NYSE:CANO) shares are down by over 62% year to date and down over 45% in the last three months.

As of this writing, Cano Health shares are trading above $3.30 with a 52-week range of $3.30 to $12.87, giving the company a market capitalization of more than $1.60 billion.

  1. NGM Biopharmaceuticals (-59%)

Founded in 2007 and headquartered in South San Francisco, Calif., this company discovers and develops therapeutics for cardio-metabolic, liver, oncologic, and ophthalmic diseases. NGM Biopharmaceuticals (NASDAQ:NGM) shares are down by almost 72% year to date and down over 69% in the last three months.

As of this writing, NGM Biopharmaceuticals shares are trading above $4.60 with a 52-week range of $2.92 to $21.63, giving the company a market cap of more than $400 million.

Latest comments

BHVN really strapped on the rocket into 2023. On June 23rd they closed $23.20
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.